As a health care professional, one of your duties is to evaluate literature and make clinical decisions for your patients. What? I didn't say it was an easy part of your job. Maybe not even a fun part. You've got to be able to separate the wheat from the chaff. To read between the lines and see through the BS. To arrive at that happy place where sound evidence-based decisions come from.

This special tl;dr two-part post will help you see some of Big Pharma's tricks--so you'll be better prepared when you read up on that new drug approved by the FDA.

Part I is like a mini journal club. We'll focus on a recent secondary analysis of the ARISTOTLE trial.

Part II will take a broader look at the other marketing practices of Big Pharma.

Practice, ProfessionalBrandon DysonMarch 30, 2016Big Pharma, Journal Club, Statistics, Data, Clinical Trials